Ionis Pharma (IONS) Q3 Revenue Tops Views

Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $120.9 million versus the consensus estimate of $116.96 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Ionis Pharmaceuticals (IONS) PT Lowered to $54 at BMO Capital Post Pelacarsen Failure
• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Braze stock tumbles 10% on weak third quarter EPS guidance